• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An ectopic pregnancy masked by follicular initiation of gonadotropin-releasing hormone agonist for pituitary desensitization prior to in vitro fertilization.

作者信息

Hemmings R, Biljan M M, Dean N, Tan S L

机构信息

McGill Reproductive Center, Department of Obstetrics and Gynecology, Royal Victoria Hospital, McGill University, Montreal, Canada.

出版信息

J Assist Reprod Genet. 1998 Mar;15(3):161-3. doi: 10.1023/a:1023017123204.

DOI:10.1023/a:1023017123204
PMID:9547694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3454974/
Abstract
摘要

相似文献

1
An ectopic pregnancy masked by follicular initiation of gonadotropin-releasing hormone agonist for pituitary desensitization prior to in vitro fertilization.一例在体外受精前使用促性腺激素释放激素激动剂启动卵泡以进行垂体脱敏治疗时被掩盖的异位妊娠。
J Assist Reprod Genet. 1998 Mar;15(3):161-3. doi: 10.1023/a:1023017123204.
2
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.在使用促性腺激素释放激素类似物抑制垂体期间，口服避孕药预处理可有效降低功能性卵巢囊肿形成的发生率。
J Assist Reprod Genet. 1998 Nov;15(10):599-604. doi: 10.1023/a:1020381310860.
3
Utero-ovarian blood flow characteristics of pituitary desensitization.垂体脱敏的子宫-卵巢血流特征
Hum Reprod. 2001 Aug;16(8):1663-70. doi: 10.1093/humrep/16.8.1663.
4
Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.口服避孕药预处理对使用促性腺激素释放激素类似物实现垂体抑制所需时间以及随后的着床率和妊娠率的影响。
Fertil Steril. 1998 Dec;70(6):1063-9. doi: 10.1016/s0015-0282(98)00333-1.
5
Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.在使用促性腺激素刺激之前，用促性腺激素释放激素类似物进行抑制：三种方案的比较。
Gynecol Obstet Invest. 1989;28(1):31-4. doi: 10.1159/000293495.
6
Do the suppression criteria in GnRH-a cycles predict in vitro fertilization outcome?GnRH-a周期中的抑制标准能否预测体外受精结局？
Gynecol Endocrinol. 1995 Jun;9(2):91-6. doi: 10.3109/09513599509160196.
7
Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Gynecol Obstet Invest. 1990;29(2):140-4. doi: 10.1159/000293320.
8
Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.长效促性腺激素释放激素激动剂联合经阴道超声引导下囊肿抽吸与单独使用长效促性腺激素释放激素激动剂对体外受精-胚胎移植妊娠结局的比较研究。
Contemp Clin Trials. 2012 Nov;33(6):1206-10. doi: 10.1016/j.cct.2012.07.009. Epub 2012 Jul 20.
9
Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization.用于体外受精的促性腺激素释放激素激动剂与促性腺激素联合进行卵巢刺激。
Fertil Steril. 1987 Apr;47(4):639-43. doi: 10.1016/s0015-0282(16)59115-8.
10
The pattern of changes in ovarian stromal and uterine artery blood flow velocities during in vitro fertilization treatment and its relationship with outcome of the cycle.体外受精治疗期间卵巢基质和子宫动脉血流速度的变化模式及其与周期结局的关系。
Ultrasound Obstet Gynecol. 1999 Jan;13(1):26-33. doi: 10.1046/j.1469-0705.1999.13010026.x.

本文引用的文献

1
Endometrial stripe thickness as a predictor of ectopic pregnancy.子宫内膜厚度作为异位妊娠的预测指标。
Fertil Steril. 1996 Sep;66(3):474-7. doi: 10.1016/s0015-0282(16)58522-7.
2
Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.使用促性腺激素释放激素激动剂布舍瑞林的长、短和超短方案与不使用该方案进行体外受精后的累积受孕率和活产率。
Am J Obstet Gynecol. 1994 Aug;171(2):513-20. doi: 10.1016/0002-9378(94)90291-7.
3
Unexpected pregnancies exposed to leuprolide acetate administered after the mid-luteal phase for ovarian stimulation.在黄体中期后给予醋酸亮丙瑞林进行卵巢刺激时发生的意外妊娠。
Hum Reprod. 1995 Jan;10(1):204-6. doi: 10.1093/humrep/10.1.204.
4
Administration of progestogens to hasten pituitary desensitization after the use of gonadotropin-releasing hormone agonist in in vitro fertilization--a prospective randomized study.在体外受精中使用促性腺激素释放激素激动剂后给予孕激素以加速垂体脱敏——一项前瞻性随机研究。
Fertil Steril. 1995 Oct;64(4):791-5. doi: 10.1016/s0015-0282(16)57856-x.
5
The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist.长效促性腺激素释放激素激动剂在卵泡早期和黄体中期给药的比较。
Fertil Steril. 1990 Aug;54(2):233-7. doi: 10.1016/s0015-0282(16)53695-4.
6
A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization.垂体脱敏后体外受精中绒毛膜促性腺激素给药最佳时机的前瞻性随机研究。
Fertil Steril. 1992 Jun;57(6):1259-64. doi: 10.1016/s0015-0282(16)55084-5.
7
The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization.在体外受精的卵巢刺激中，促性腺激素释放激素激动剂的长方案给药优于短方案。
Fertil Steril. 1992 Apr;57(4):810-4. doi: 10.1016/s0015-0282(16)54963-2.